Page 7 - Lexaria Bioscience News Today

LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...

Drug Delivery Platform Innovator With Multiple Mainstream Applications Investor Presentation Q2 2023 ...

South32 (OTCMKTS:SOUHY – Free Report) and Lexaria Bioscience (OTCMKTS:LXRP – Free Report) are both basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, profitability, risk, earnings and dividends. Profitability This table compares South32 and Lexaria Bioscience’s net margins, […]

Shares of Lexaria Bioscience Corp. (OTCMKTS:LXRP – Free Report) passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $0.22 and traded as low as $0.21. Lexaria Bioscience shares last traded at $0.22, with a volume of 2,151,500 shares. Lexaria Bioscience Stock Performance The […]

Lexaria Bioscience (NASDAQ:LEXX – Get Rating) and Mallinckrodt (OTCMKTS:MNKKQ – Get Rating) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, earnings, institutional ownership, analyst recommendations and dividends. Analyst Recommendations This is a breakdown of recent ratings and price […]

Lexaria Bioscience Corp. (NASDAQ:LEXX – Get Rating) was the recipient of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 343,000 shares, an increase of 31.9% from the May 15th total of 260,100 shares. Currently, 4.7% of the shares of the company are sold […]

Lexaria Bioscience Corp. (NASDAQ:LEXX – Get Rating) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 343,000 shares, a growth of 31.9% from the May 15th total of 260,100 shares. Approximately 4.7% of the company’s shares are short sold. Based […]

KELOWNA, BC / ACCESSWIRE / June 12, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the appointment of

Lexaria Biosciences powerful, proprietary drug delivery technology, DehydraTECH has the potential to disrupt multiple categories as the company continues to receive positive results from clinical... | June 7, 2023

Lexaria Bioscience Corp. (NASDAQ:LEXX – Get Rating)’s share price traded up 13.2% during mid-day trading on Tuesday . The stock traded as high as $0.88 and last traded at $0.78. 1,658,700 shares changed hands during trading, an increase of 1,683% from the average session volume of 93,028 shares. The stock had previously closed at $0.69. […]